A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care
Status epilepticus is a common neurological emergency, with overall mortality around 20%. Over half of cases are first time presentations of seizures. The pathological process by which spontaneous seizures are generated arises from an imbalance in excitatory and inhibitory neuronal networks, which i...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2019
|
| _version_ | 1826291059181748224 |
|---|---|
| author | Prisco, L Ganau, M Aurangzeb, S Moswela, O Hallett, C Raby, S Fitzgibbon, K Kearns, C Sen, A |
| author_facet | Prisco, L Ganau, M Aurangzeb, S Moswela, O Hallett, C Raby, S Fitzgibbon, K Kearns, C Sen, A |
| author_sort | Prisco, L |
| collection | OXFORD |
| description | Status epilepticus is a common neurological emergency, with overall mortality around 20%. Over half of cases are first time presentations of seizures. The pathological process by which spontaneous seizures are generated arises from an imbalance in excitatory and inhibitory neuronal networks, which if unchecked, can result in alterations in intracellular signalling pathways and electrolyte shifts, which bring about changes in the blood brain barrier, neuronal cell death and eventually cerebral atrophy. This narrative review focusses on the treatment of status epilepticus in adults. Anaesthetic agents interrupt neuronal activity by enhancing inhibitory or decreasing excitatory transmission, primarily via GABA and NMDA receptors. Intravenous anaesthetic agents are commonly used as second or third line drugs in the treatment of refractory status epilepticus, but the optimal timing and choice of anaesthetic drug has not yet been established by high quality evidence. Titration of antiepileptic and anaesthetic drugs in critically ill patients presents a particular challenge, due to alterations in drug absorbtion and metabolism as well as changes in drug distrubution, which arise from fluid shifts and altered protein binding. Furthermore, side effects associated with prolonged infusions of anaesthetic drugs can lead to multi-organ dysfunction and a need for critical care support. Electroencelography can identify patterns of burst suppression, which may be a target to guide weaning of intravenous therapy. Continuous elctroencephalography has the potential to directly impact clinical care, but despite its utility, major barriers exist which have limited its widespread use in clinical practice. A flow chart outlining the timing and dosage of anaesthetic agents used at our institution is provided. |
| first_indexed | 2024-03-07T02:53:41Z |
| format | Journal article |
| id | oxford-uuid:ae8cbbeb-1d2c-4389-9153-5536f9adebe0 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:53:41Z |
| publishDate | 2019 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:ae8cbbeb-1d2c-4389-9153-5536f9adebe02022-03-27T03:43:22ZA pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical careJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ae8cbbeb-1d2c-4389-9153-5536f9adebe0EnglishSymplectic ElementsElsevier2019Prisco, LGanau, MAurangzeb, SMoswela, OHallett, CRaby, SFitzgibbon, KKearns, CSen, AStatus epilepticus is a common neurological emergency, with overall mortality around 20%. Over half of cases are first time presentations of seizures. The pathological process by which spontaneous seizures are generated arises from an imbalance in excitatory and inhibitory neuronal networks, which if unchecked, can result in alterations in intracellular signalling pathways and electrolyte shifts, which bring about changes in the blood brain barrier, neuronal cell death and eventually cerebral atrophy. This narrative review focusses on the treatment of status epilepticus in adults. Anaesthetic agents interrupt neuronal activity by enhancing inhibitory or decreasing excitatory transmission, primarily via GABA and NMDA receptors. Intravenous anaesthetic agents are commonly used as second or third line drugs in the treatment of refractory status epilepticus, but the optimal timing and choice of anaesthetic drug has not yet been established by high quality evidence. Titration of antiepileptic and anaesthetic drugs in critically ill patients presents a particular challenge, due to alterations in drug absorbtion and metabolism as well as changes in drug distrubution, which arise from fluid shifts and altered protein binding. Furthermore, side effects associated with prolonged infusions of anaesthetic drugs can lead to multi-organ dysfunction and a need for critical care support. Electroencelography can identify patterns of burst suppression, which may be a target to guide weaning of intravenous therapy. Continuous elctroencephalography has the potential to directly impact clinical care, but despite its utility, major barriers exist which have limited its widespread use in clinical practice. A flow chart outlining the timing and dosage of anaesthetic agents used at our institution is provided. |
| spellingShingle | Prisco, L Ganau, M Aurangzeb, S Moswela, O Hallett, C Raby, S Fitzgibbon, K Kearns, C Sen, A A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care |
| title | A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care |
| title_full | A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care |
| title_fullStr | A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care |
| title_full_unstemmed | A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care |
| title_short | A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care |
| title_sort | pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super refractory status epilepticus in critical care |
| work_keys_str_mv | AT priscol apragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT ganaum apragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT aurangzebs apragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT moswelao apragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT hallettc apragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT rabys apragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT fitzgibbonk apragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT kearnsc apragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT sena apragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT priscol pragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT ganaum pragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT aurangzebs pragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT moswelao pragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT hallettc pragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT rabys pragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT fitzgibbonk pragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT kearnsc pragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare AT sena pragmaticapproachtointravenousanaestheticsandelectroencephalographicendpointsforthetreatmentofrefractoryandsuperrefractorystatusepilepticusincriticalcare |